Global Cardiovascular Disease Monitoring and Diagnostic Devices Industry
Global Cardiovascular Disease Monitoring and Diagnostic Devices Market to Reach $3. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.
New York, Sept. 07, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cardiovascular Disease Monitoring and Diagnostic Devices Industry" - https://www.reportlinker.com/p05205318/?utm_source=GNW
2 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. ECG Systems, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Holter Monitors segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $592.1 Million, While China is Forecast to Grow at 9.3% CAGR
The Cardiovascular Disease Monitoring and Diagnostic Devices market in the U.S. is estimated at US$592.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$706.9 Million by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Implantable Loop Recorders Segment to Record 7.4% CAGR
In the global Implantable Loop Recorders segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$82.9 Million in the year 2020 will reach a projected size of US$131.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447.5 Million by the year 2027, while Latin America will expand at a 8.7% CAGR through the analysis period. We bring years of research experience to this 19th edition of our report. The 204-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
BioTelemetry Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
GE Healthcare UK Ltd.
Koninklijke Philips N.V
Medtronic Plc.
Mortara Instrument Inc.
Nihon Kohden Corporation
Philips Healthcare
Schiller AG
Spacelabs Healthcare Inc.
St. Jude Medical Inc.
Welch Allyn
Read the full report: https://www.reportlinker.com/p05205318/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Cardiovascular Diseases: Facts & Figures
Recent Market Activity
CVD Monitoring and Diagnostic Devices on a High Growth Trajectory
The US Dominates, Asia-Pacific to Witness Fastest Growth
ECG Systems Lead the CVD Diagnostics and Monitoring Market
Competitive Scenario
Holter Monitoring Systems: An Established Market, Facing Threats
Ambulatory Cardiac Monitoring Devices - A Comparison of Holter
and Other Devices
Evolution of Cardiac Monitoring Devices
A Comparison of Key Features of Three Major Ambulatory ECG
Systems- Holter Monitoring, Event Monitoring and MCOT
Benefits and Drawbacks of Three Major Primary Cardiac Event
Monitoring Systems - Holter Monitoring, Event Monitoring and
MCOT
Competitive Landscape
Implantable Loop Recorder (ILR) to Register the Fastest Growth
ECG Management Systems: Integral for Data Storage
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Cardiovascular Disease Monitoring and Diagnostic Devices
Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
2. FOCUS ON SELECT PLAYERS
BioTelemetry, Inc. (USA)
BIOTRONIK SE & Co. KG (Germany)
Boston Scientific Corporation (USA)
GE Healthcare UK Ltd. (UK)
Koninklijke Philips N.V, (USA)
Medtronic Plc. (USA)
Mortara Instrument, Inc. (USA)
Nihon Kohden Corporation (Japan)
Philips Healthcare (USA)
Schiller AG (Switzerland)
Spacelabs Healthcare, Inc. (USA)
St. Jude Medical, Inc. (USA)
Welch Allyn (USA)
3. MARKET TRENDS & DRIVERS
Global Menace of Cardiovascular Disease (CVD) - A Major Growth
Driver
Aging Population Drives Demand
Increase in Healthcare Spending Bodes Well for Cardiac
Monitoring Market
Risk of CAD in Obesity Offers Prospects for Cardiac Monitoring
Devices
Diabetics at Higher Risk of Heart Diseases
Increasing Preference for Homecare Drives Cardiac Monitoring
Devices Demand
SELECT PRODUCT TRENDS/ADVANCEMENTS
Holter Devices Continue to Witness Technological Advances
Disposable Devices - the New Trend in Holter Monitors
ZIO Wireless Patch Holter Monitors
Mobile Cardiac Telemetry (MCT): A Potential Threat to Holter
Monitors
Remote Monitoring Reduces Hospital Admissions and Readmissions
Innovations in Remote ECG Monitoring
Advancements in ECG Management Systems
Third-Party Integration
GE Muse Version 9 ECG Management System
Mobile Access for ECG Waveforms
Others Advancements in ECG Management Systems
4. GLOBAL MARKET PERSPECTIVE
Table 1: Cardiovascular Disease Monitoring and Diagnostic
Devices Global Market Estimates and Forecasts in US$ Thousand
by Region/Country: 2020-2027
Table 2: Cardiovascular Disease Monitoring and Diagnostic
Devices Global Retrospective Market Scenario in US$ Thousand by
Region/Country: 2012-2019
Table 3: Cardiovascular Disease Monitoring and Diagnostic
Devices Market Share Shift across Key Geographies Worldwide:
2012 VS 2020 VS 2027
Table 4: ECG Systems (Segment) World Market by Region/Country
in US$ Thousand: 2020 to 2027
Table 5: ECG Systems (Segment) Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019
Table 6: ECG Systems (Segment) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Holter Monitors (Segment) Potential Growth Markets
Worldwide in US$ Thousand: 2020 to 2027
Table 8: Holter Monitors (Segment) Historic Market Perspective
by Region/Country in US$ Thousand: 2012 to 2019
Table 9: Holter Monitors (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Implantable Loop Recorders (Segment) Geographic
Market Spread Worldwide in US$ Thousand: 2020 to 2027
Table 11: Implantable Loop Recorders (Segment) Region Wise
Breakdown of Global Historic Demand in US$ Thousand: 2012 to
2019
Table 12: Implantable Loop Recorders (Segment) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027
Table 13: Other Segments (Segment) World Market Estimates and
Forecasts by Region/Country in US$ Thousand: 2020 to 2027
Table 14: Other Segments (Segment) Market Historic Review by
Region/Country in US$ Thousand: 2012 to 2019
Table 15: Other Segments (Segment) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cardiovascular Disease Monitoring and Diagnostic Devices
Market Share (in %) by Company: 2020 & 2025
Market Analytics
Table 16: United States Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Projections in US$
Thousand by Segment: 2020 to 2027
Table 17: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in the United States by Segment: A Historic
Review in US$ Thousand for 2012-2019
Table 18: United States Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
CANADA
Table 19: Canadian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020 to 2027
Table 20: Canadian Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Review by Segment in US$
Thousand: 2012-2019
Table 21: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Canada: Percentage Share Breakdown of Sales
by Segment for 2012, 2020, and 2027
JAPAN
Table 22: Japanese Market for Cardiovascular Disease Monitoring
and Diagnostic Devices: Annual Sales Estimates and Projections
in US$ Thousand by Segment for the Period 2020-2027
Table 23: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Japan: Historic Sales Analysis in US$
Thousand by Segment for the Period 2012-2019
Table 24: Japanese Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
CHINA
Table 25: Chinese Cardiovascular Disease Monitoring and
Diagnostic Devices Market Growth Prospects in US$ Thousand by
Segment for the Period 2020-2027
Table 26: Cardiovascular Disease Monitoring and Diagnostic
Devices Historic Market Analysis in China in US$ Thousand by
Segment: 2012-2019
Table 27: Chinese Cardiovascular Disease Monitoring and
Diagnostic Devices Market by Segment: Percentage Breakdown of
Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Cardiovascular Disease Monitoring and Diagnostic
Devices Market: Competitor Market Share Scenario (in %) for
2020 & 2025
Market Analytics
Table 28: European Cardiovascular Disease Monitoring and
Diagnostic Devices Market Demand Scenario in US$ Thousand by
Region/Country: 2020-2027
Table 29: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Europe: A Historic Market Perspective in US$
Thousand by Region/Country for the Period 2012-2019
Table 30: European Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Shift by Region/Country: 2012
VS 2020 VS 2027
Table 31: European Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020-2027
Table 32: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Europe in US$ Thousand by Segment: A Historic
Review for the Period 2012-2019
Table 33: European Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
FRANCE
Table 34: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in France by Segment: Estimates and Projections
in US$ Thousand for the Period 2020-2027
Table 35: French Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Scenario in US$ Thousand by
Segment: 2012-2019
Table 36: French Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
GERMANY
Table 37: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Germany: Recent Past, Current and Future
Analysis in US$ Thousand by Segment for the Period 2020-2027
Table 38: German Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Analysis in US$ Thousand by
Segment: 2012-2019
Table 39: German Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
ITALY
Table 40: Italian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Growth Prospects in US$ Thousand by
Segment for the Period 2020-2027
Table 41: Cardiovascular Disease Monitoring and Diagnostic
Devices Historic Market Analysis in Italy in US$ Thousand by
Segment: 2012-2019
Table 42: Italian Cardiovascular Disease Monitoring and
Diagnostic Devices Market by Segment: Percentage Breakdown of
Sales for 2012, 2020, and 2027
UNITED KINGDOM
Table 43: United Kingdom Market for Cardiovascular Disease
Monitoring and Diagnostic Devices: Annual Sales Estimates and
Projections in US$ Thousand by Segment for the Period 2020-2027
Table 44: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in the United Kingdom: Historic Sales Analysis
in US$ Thousand by Segment for the Period 2012-2019
Table 45: United Kingdom Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
SPAIN
Table 46: Spanish Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020 to 2027
Table 47: Spanish Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Review by Segment in US$
Thousand: 2012-2019
Table 48: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Spain: Percentage Share Breakdown of Sales by
Segment for 2012, 2020, and 2027
RUSSIA
Table 49: Russian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Projections in US$
Thousand by Segment: 2020 to 2027
Table 50: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Russia by Segment: A Historic Review in US$
Thousand for 2012-2019
Table 51: Russian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
REST OF EUROPE
Table 52: Rest of Europe Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020-2027
Table 53: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Rest of Europe in US$ Thousand by Segment:
A Historic Review for the Period 2012-2019
Table 54: Rest of Europe Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
ASIA-PACIFIC
Table 55: Asia-Pacific Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Region/Country: 2020-2027
Table 56: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Asia-Pacific: Historic Market Analysis in US$
Thousand by Region/Country for the Period 2012-2019
Table 57: Asia-Pacific Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Region/Country:
2012 VS 2020 VS 2027
Table 58: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Asia-Pacific by Segment: Estimates and
Projections in US$ Thousand for the Period 2020-2027
Table 59: Asia-Pacific Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Scenario in US$ Thousand by
Segment: 2012-2019
Table 60: Asia-Pacific Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
AUSTRALIA
Table 61: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Australia: Recent Past, Current and Future
Analysis in US$ Thousand by Segment for the Period 2020-2027
Table 62: Australian Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Analysis in US$ Thousand by
Segment: 2012-2019
Table 63: Australian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
INDIA
Table 64: Indian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020 to 2027
Table 65: Indian Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Review by Segment in US$
Thousand: 2012-2019
Table 66: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in India: Percentage Share Breakdown of Sales by
Segment for 2012, 2020, and 2027
SOUTH KOREA
Table 67: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in South Korea: Recent Past, Current and Future
Analysis in US$ Thousand by Segment for the Period 2020-2027
Table 68: South Korean Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Analysis in US$ Thousand by
Segment: 2012-2019
Table 69: Cardiovascular Disease Monitoring and Diagnostic
Devices Market Share Distribution in South Korea by Segment:
2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 70: Rest of Asia-Pacific Market for Cardiovascular
Disease Monitoring and Diagnostic Devices: Annual Sales
Estimates and Projections in US$ Thousand by Segment for the
Period 2020-2027
Table 71: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Rest of Asia-Pacific: Historic Sales Analysis
in US$ Thousand by Segment for the Period 2012-2019
Table 72: Rest of Asia-Pacific Cardiovascular Disease
Monitoring and Diagnostic Devices Market Share Analysis by
Segment: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 73: Latin American Cardiovascular Disease Monitoring and
Diagnostic Devices Market Trends by Region/Country in US$
Thousand: 2020-2027
Table 74: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Latin America in US$ Thousand by
Region/Country: A Historic Perspective for the Period 2012-2019
Table 75: Latin American Cardiovascular Disease Monitoring and
Diagnostic Devices Market Percentage Breakdown of Sales by
Region/Country: 2012, 2020, and 2027
Table 76: Latin American Cardiovascular Disease Monitoring and
Diagnostic Devices Market Growth Prospects in US$ Thousand by
Segment for the Period 2020-2027
Table 77: Cardiovascular Disease Monitoring and Diagnostic
Devices Historic Market Analysis in Latin America in US$
Thousand by Segment: 2012-2019
Table 78: Latin American Cardiovascular Disease Monitoring and
Diagnostic Devices Market by Segment: Percentage Breakdown of
Sales for 2012, 2020, and 2027
ARGENTINA
Table 79: Argentinean Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020-2027
Table 80: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Argentina in US$ Thousand by Segment:
A Historic Review for the Period 2012-2019
Table 81: Argentinean Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
BRAZIL
Table 82: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Brazil by Segment: Estimates and Projections
in US$ Thousand for the Period 2020-2027
Table 83: Brazilian Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Scenario in US$ Thousand by
Segment: 2012-2019
Table 84: Brazilian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
MEXICO
Table 85: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Mexico: Recent Past, Current and Future
Analysis in US$ Thousand by Segment for the Period 2020-2027
Table 86: Mexican Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market Analysis in US$ Thousand by
Segment: 2012-2019
Table 87: Mexican Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
REST OF LATIN AMERICA
Table 88: Rest of Latin America Cardiovascular Disease
Monitoring and Diagnostic Devices Market Estimates and
Projections in US$ Thousand by Segment: 2020 to 2027
Table 89: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Rest of Latin America by Segment: A Historic
Review in US$ Thousand for 2012-2019
Table 90: Rest of Latin America Cardiovascular Disease
Monitoring and Diagnostic Devices Market Share Breakdown by
Segment: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 91: The Middle East Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Region/Country: 2020-2027
Table 92: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in the Middle East by Region/Country in US$
Thousand: 2012-2019
Table 93: The Middle East Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Region/Country:
2012, 2020, and 2027
Table 94: The Middle East Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020 to 2027
Table 95: The Middle East Cardiovascular Disease Monitoring and
Diagnostic Devices Historic Market by Segment in US$ Thousand:
2012-2019
Table 96: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in the Middle East: Percentage Share Breakdown
of Sales by Segment for 2012,2020, and 2027
IRAN
Table 97: Iranian Market for Cardiovascular Disease Monitoring
and Diagnostic Devices: Annual Sales Estimates and Projections
in US$ Thousand by Segment for the Period 2020-2027
Table 98: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Iran: Historic Sales Analysis in US$ Thousand
by Segment for the Period 2012-2019
Table 99: Iranian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Analysis by Segment: 2012 VS
2020 VS 2027
ISRAEL
Table 100: Israeli Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Forecasts in US$
Thousand by Segment: 2020-2027
Table 101: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Israel in US$ Thousand by Segment: A Historic
Review for the Period 2012-2019
Table 102: Israeli Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
SAUDI ARABIA
Table 103: Saudi Arabian Cardiovascular Disease Monitoring and
Diagnostic Devices Market Growth Prospects in US$ Thousand by
Segment for the Period 2020-2027
Table 104: Cardiovascular Disease Monitoring and Diagnostic
Devices Historic Market Analysis in Saudi Arabia in US$
Thousand by Segment: 2012-2019
Table 105: Saudi Arabian Cardiovascular Disease Monitoring and
Diagnostic Devices Market by Segment: Percentage Breakdown of
Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
Table 106: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in the United Arab Emirates: Recent Past,
Current and Future Analysis in US$ Thousand by Segment for the
Period 2020-2027
Table 107: United Arab Emirates Cardiovascular Disease
Monitoring and Diagnostic Devices Historic Market Analysis in
US$ Thousand by Segment: 2012-2019
Table 108: Cardiovascular Disease Monitoring and Diagnostic
Devices Market Share Distribution in United Arab Emirates by
Segment: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
Table 109: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Rest of Middle East: Recent Past, Current and
Future Analysis in US$ Thousand by Segment for the Period
2020-2027
Table 110: Rest of Middle East Cardiovascular Disease
Monitoring and Diagnostic Devices Historic Market Analysis in
US$ Thousand by Segment: 2012-2019
Table 111: Rest of Middle East Cardiovascular Disease
Monitoring and Diagnostic Devices Market Share Breakdown by
Segment: 2012 VS 2020 VS 2027
AFRICA
Table 112: African Cardiovascular Disease Monitoring and
Diagnostic Devices Market Estimates and Projections in US$
Thousand by Segment: 2020 to 2027
Table 113: Cardiovascular Disease Monitoring and Diagnostic
Devices Market in Africa by Segment: A Historic Review in US$
Thousand for 2012-2019
Table 114: African Cardiovascular Disease Monitoring and
Diagnostic Devices Market Share Breakdown by Segment: 2012 VS
2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 60
Read the full report: https://www.reportlinker.com/p05205318/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001